Company Listing
Portola Pharmaceuticals

Portola is discovering and developing novel anti-platelet therapeutics for the treatment of acute and chronic thrombotic indications. Portola’s founders are principally founders of the team that developed the cardiovascular product, Integrilin. The company went public in May 2013.

BACK
Location
South San Francisco, California
Website Address

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Portola is discovering and developing novel anti-platelet therapeutics for the treatment of acute and chronic thrombotic indications. Portola’s founders are principally founders of the team that developed the cardiovascular product, Integrilin. The company went public in May 2013.

Location
South San Francisco, California
Website Address
BACK
 
Copyright Abingworth 2017